<!DOCTYPE html>
<html lang="en-US">
<head>
  <meta http-equiv="content-type" content="text/html; charset=UTF-8" />
  <meta name="generator" content="Madoko, version 1.2.3" />
  <meta name="viewport" content="initial-scale=1.0" />
  <meta name="author" content="Dr. Jagdish Varma" />
  <title>SSRI IN COVID 19</title>
  <style type="text/css"  class="link">
  /*# sourceURL=madoko.css */
  
  .madoko .toc>.tocblock .tocblock .tocblock {
    margin-left: 2.25em;
  }
  .madoko .toc>.tocblock .tocblock {
    margin-left: 1.5em;
  }
  .madoko .toc-contents>.tocblock>.tocitem {
    font-weight: bold;
  }
  .madoko .toc {
    margin-top: 1em;
  }
  .madoko p.para-continue {
    margin-bottom: 0pt;
  }
  .madoko .para-block+p {
    margin-top: 0pt;
  }
  .madoko ul.para-block, .madoko ol.para-block {
    margin-top: 0pt;
    margin-bottom: 0pt;
  }
  .madoko ul.para-end, .madoko ol.para-end {
    margin-bottom: 1em;
  }
  .madoko dl {
    margin-left: 0em;
  }
  .madoko blockquote {
    font-style: italic;
  }
  .madoko a.localref {
    text-decoration: none;
  }
  .madoko a.localref:hover {
    text-decoration: underline;
  }
  .madoko .footnotes {
    font-size: smaller;
    margin-top: 2em;
  }
  .madoko .footnotes hr {
    width: 50%;
    text-align: left;
  }
  .madoko .footnote {
    margin-left: 1em;
  }
  .madoko .footnote-before {
    margin-left: -1em;
    width: 1em;
    display: inline-block;
  }
  .madoko .align-center, .madoko .align-center>p {
    text-align: center !important;
  }
  .madoko .align-center pre {
    text-align: left;
  }
  .madoko .align-center>* {
    margin-left: auto !important;
    margin-right: auto !important;
  }
  .madoko .align-left, .madoko .align-left>p {
    text-align: left !important;
  }
  .madoko .align-left>* {
    margin-left: 0pt !important;
    margin-right: auto !important;
  }
  .madoko .align-right, .madoko .align-right>p {
    text-align: right !important;
  }
  .madoko .align-right>* {
    margin-left: auto !important;
    margin-right: 0pt !important;
  }
  .madoko .align-center>table,
  .madoko .align-left>table,
  .madoko .align-right>table {
    text-align: left !important;
  }
  .madoko .equation-before {
    float: right;
  }
  .madoko .bibitem {
    font-size: smaller;
  }
  .madoko .bibsearch {
    font-size: x-small;
    text-decoration:none;
    color: black;
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  .madoko .block, .madoko .figure, .madoko .bibitem, .madoko .equation, .madoko div.math {
    margin-top: 1ex;
    margin-bottom: 1ex;
  }
  .madoko .figure {
    padding: 0.5em;
    margin-left: 0pt;
    margin-right: 0pt;
  }
  .madoko .hidden {
    display: none;
  }
  .madoko .invisible {
    visibility: hidden;
  }
  .madoko.preview .invisible {
    visibility: visible;
    opacity: 0.5;
  }
  .madoko code.code, .madoko span.code {
    white-space: pre-wrap;
  }
  .madoko hr, hr.madoko {
    border: none;
    border-bottom: black solid 1px;
    margin-bottom: 0.5ex;
  }
  .madoko .framed>*:first-child {
    margin-top: 0pt;
  }
  .madoko .framed>*:last-child {
    margin-bottom: 0pt;
  }
  .madoko ul.list-style-type-dash {
      list-style-type: none !important;
  }
  .madoko ul.list-style-type-dash > li:before {
      content: "\2013";
      position: absolute;
      margin-left: -1em;
  }
  .madoko table.madoko {
    border-collapse: collapse;
  }
  .madoko td, .madoko th {
    padding: 0ex 0.5ex;
    margin: 0pt;
    vertical-align: top;
  }
  .madoko .cell-border-left {
    border-left: 1px solid black;
  }
  .madoko .cell-border-right {
    border-right: 1px solid black;
  }
  .madoko thead>tr:first-child>.cell-line,
  .madoko tbody:first-child>tr:first-child>.cell-line {
    border-top: 1px solid black;
    border-bottom: none;
  }
  .madoko .cell-line, .madoko .cell-double-line {
    border-bottom: 1px solid black;
    border-top: none;
  }
  .madoko .cell-double-line {
    border-top: 1px solid black;
    padding-top: 1.5px !important;
  }
  .madoko .input-mathpre .MathJax_Display {
    text-align: left !important;
  }
  .madoko div.input-mathpre {
    text-align: left;
    margin-top: 1.5ex;
    margin-bottom: 1ex;
  }
  .madoko .math-rendering {
    text-align: left;
    white-space: pre;
    color: gray;
  }
  .madoko .mathdisplay {
    text-align: center;
  }
  .madoko span.math-rendering {
    display:inline-block;
    width:8em;
    overflow-x:auto;
    font-size:70%;
  }
  .madoko span.math-rendering::-webkit-scrollbar {
    width:4px;
  }
  .madoko .pretty table {
    border-collapse: collapse;
  }
  .madoko .pretty td {
    padding: 0em;
  }
  .madoko .pretty td.empty {
    min-width: 1.5ex;
  }
  .madoko .pretty td.expander {
    width: 100em;
  }
  body.madoko, .madoko .serif {
    font-family: Cambria,"Times New Roman","Liberation Serif","Times",serif;
  }
  .madoko .sans-serif {
    font-family: "Calibri", "Optima", sans-serif;
  }
  .madoko .symbol {
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  body.madoko {
    -webkit-text-size-adjust: 100%;       
    text-rendering: optimizeLegibility;
  }
  body.madoko {
    max-width: 88ex; 
    margin: 1em auto;
    padding: 0em 2em;
  }
  body.preview.madoko {
    padding: 0em 1em;
  }
  .madoko p {
    text-align: justify;
  }
  .madoko h1, .madoko h2, .madoko h3, .madoko h4 {
    margin-top: 1.22em;
    margin-bottom: 1ex;
  }
  .madoko h1+p, .madoko h2+p, .madoko h3+p, .madoko h4+p, .madoko h5+p  {
    margin-top: 1ex;
  }
  .madoko h5, .madoko h6 {
    margin-top: 1ex;
    font-size: 1em;
  }
  .madoko h5 {
    margin-bottom: 0.5ex;
  }
  .madoko h5 + p {
    margin-top: 0.5ex;
  }
  .madoko h6 {
    margin-bottom: 0pt;
  }
  .madoko h6 + p {
    margin-top: 0pt;
  }
  .madoko pre, .madoko code, .madoko kbd, .madoko samp, .madoko tt,
  .madoko .monospace, .madoko .token-indent, .madoko .reveal pre, .madoko .reveal code, .madoko .email {
    font-family: Consolas,"Andale Mono WT","Andale Mono",Lucida Console,Monaco,monospace,monospace;
    font-size: 0.85em;
  }
  .madoko pre code, .madoko .token-indent {
    font-size: 0.95em;
  }
  .madoko pre code {
    font-family: inherit !important;
  }
  .madoko ol.linenums li {
    background-color: white;
    list-style-type: decimal;
  }
  .madoko .remote {
    background-color: #F0FFF0;
  }
  .madoko .remote + * {
    margin-top: 0pt;
  }
  @media print {
    body.madoko {
      font-size: 10pt;
    }
    @page {
      margin: 1in 1.5in;
    }
  }
  @media only screen and (max-device-width:1024px) {
    body.madoko {
      padding: 0em 0.5em;
    }
    .madoko li {
      text-align: left;
    }
  }
  
    </style>
  
  </head>
<body class="madoko">

<div class="body madoko" style="line-adjust:0">

<div class="titleblock align-center para-block" data-line="6" style="text-align:center;line-adjust:0">
<div class="titleheader align-center" data-line="6" style="text-align:center;line-adjust:0">
<div class="title para-block" data-line="6" style="font-size:xx-large;font-weight:bold;margin-bottom:0.5ex;line-adjust:0"><span data-line="6"></span>SSRI IN COVID 19</div></div>
<div class="authors align-center" data-line="11" style="text-align:center;width:80%;line-adjust:0"><table class="authorrow columns block" data-line="11" style="margin-top:2ex;width:100%;line-adjust:0">
<tbody><tr><td class="author column" data-line="11" style="text-align:center;line-adjust:0">
<div class="authorname" data-line="11" style="font-size:large;line-adjust:0"><span data-line="11"></span>Dr. Jagdish Varma</div>
<div class="authoraddress" data-line="14" style="line-adjust:0"><span data-line="14"></span>Professor of Psychiatry, Bhaikaka University, Karamsad</div></td></tr></tbody></table></div></div><span data-line="8"></span>
<nav class="toc toc-contents"><h2 id="sec-contents" class="clearnum h1 heading-contents" data-heading-depth="1" style="display:block">Contents</h2>
<div class="tocblock tocblock1">
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-the-possible-immunoregulatory-and-anti-inflammatory-effects-of-selective-serotonin-reuptake-inhibitors-in-coronavirus-disease-patients" data-toc-depth="1" data-toc-line="[1]{.heading-label}.&#8194;The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients" style="toctarget:sec-the-possible-immunoregulatory-and-anti-inflammatory-effects-of-selective-serotonin-reuptake-inhibitors-in-coronavirus-disease-patients"><a href="#sec-the-possible-immunoregulatory-and-anti-inflammatory-effects-of-selective-serotonin-reuptake-inhibitors-in-coronavirus-disease-patients" class="localref"><span class="heading-label">1</span>.&#8194;The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients</a></div>
<div class="tocblock tocblock2">
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-hamed-et-al-medical-hypothesis-2020" data-toc-depth="2" data-toc-line="[1.1]{.heading-label}.&#8194;Hamed et al Medical Hypothesis 2020" style="toctarget:sec-hamed-et-al-medical-hypothesis-2020"><a href="#sec-hamed-et-al-medical-hypothesis-2020" class="localref"><span class="heading-label">1.1</span>.&#8194;Hamed et al Medical Hypothesis 2020</a></div>
<div class="tocblock tocblock3">
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-immune-dysregulation-in-covid-19" data-toc-depth="3" data-toc-line="[1.1.1]{.heading-label}.&#8194;Immune dysregulation in COVID-19" style="toctarget:sec-immune-dysregulation-in-covid-19"><a href="#sec-immune-dysregulation-in-covid-19" class="localref"><span class="heading-label">1.1.1</span>.&#8194;Immune dysregulation in COVID-19</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-5-ht-and-immnunity" data-toc-depth="3" data-toc-line="[1.1.2]{.heading-label}.&#8194;5-HT and immnunity" style="toctarget:sec-5-ht-and-immnunity"><a href="#sec-5-ht-and-immnunity" class="localref"><span class="heading-label">1.1.2</span>.&#8194;5-HT and immnunity</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-hypothesis" data-toc-depth="3" data-toc-line="[1.1.3]{.heading-label}.&#8194;Hypothesis" style="toctarget:sec-hypothesis"><a href="#sec-hypothesis" class="localref"><span class="heading-label">1.1.3</span>.&#8194;Hypothesis</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-which-ssri-is-suited" data-toc-depth="3" data-toc-line="[1.1.4]{.heading-label}.&#8194;Which SSRI is suited?" style="toctarget:sec-which-ssri-is-suited"><a href="#sec-which-ssri-is-suited" class="localref"><span class="heading-label">1.1.4</span>.&#8194;Which SSRI is suited?</a></div></div></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19---a-randomized-clinical-trial" data-toc-depth="1" data-toc-line="[2]{.heading-label}.&#8194;Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 - A Randomized Clinical Trial" style="toctarget:sec-fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19---a-randomized-clinical-trial"><a href="#sec-fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19---a-randomized-clinical-trial" class="localref"><span class="heading-label">2</span>.&#8194;Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 - A Randomized Clinical Trial</a></div>
<div class="tocblock tocblock2">
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-lenze-et-al-jama-2020" data-toc-depth="2" data-toc-line="[2.1]{.heading-label}.&#8194;Lenze et al JAMA 2020" style="toctarget:sec-lenze-et-al-jama-2020"><a href="#sec-lenze-et-al-jama-2020" class="localref"><span class="heading-label">2.1</span>.&#8194;Lenze et al JAMA 2020</a></div></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-association-between-antidepressant-use-and-reduced-risk-of-intubation-or-death-in-hospitalized-patients-with-covid-19--results-from-an-observational-study" data-toc-depth="1" data-toc-line="[3]{.heading-label}.&#8194;Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study" style="toctarget:sec-association-between-antidepressant-use-and-reduced-risk-of-intubation-or-death-in-hospitalized-patients-with-covid-19--results-from-an-observational-study"><a href="#sec-association-between-antidepressant-use-and-reduced-risk-of-intubation-or-death-in-hospitalized-patients-with-covid-19--results-from-an-observational-study" class="localref"><span class="heading-label">3</span>.&#8194;Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study</a></div>
<div class="tocblock tocblock2">
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-hortel-el-al-molecular-psychiatry-2021" data-toc-depth="2" data-toc-line="[3.1]{.heading-label}.&#8194;Hortel el al Molecular Psychiatry 2021" style="toctarget:sec-hortel-el-al-molecular-psychiatry-2021"><a href="#sec-hortel-el-al-molecular-psychiatry-2021" class="localref"><span class="heading-label">3.1</span>.&#8194;Hortel el al Molecular Psychiatry 2021</a></div></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-bottom-line" data-toc-depth="1" data-toc-line="[4]{.heading-label}.&#8194;Bottom line" style="toctarget:sec-bottom-line"><a href="#sec-bottom-line" class="localref"><span class="heading-label">4</span>.&#8194;Bottom line</a></div></div></nav><h2 id="sec-the-possible-immunoregulatory-and-anti-inflammatory-effects-of-selective-serotonin-reuptake-inhibitors-in-coronavirus-disease-patients" class="h1" data-line="10" data-heading-depth="1" style="display:block"><span data-line="10"></span><span class="heading-before"><span class="heading-label">1</span>.&#8194;</span><span data-line="10"></span>The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients</h2><h3 id="sec-hamed-et-al-medical-hypothesis-2020" class="h2" data-line="12" data-heading-depth="2" style="display:block"><span data-line="12"></span><span class="heading-before"><span class="heading-label">1.1</span>.&#8194;</span><span data-line="12"></span>Hamed et al Medical Hypothesis 2020</h3><h4 id="sec-immune-dysregulation-in-covid-19" class="h3" data-line="14" data-heading-depth="3" style="display:block"><span data-line="14"></span><span class="heading-before"><span class="heading-label">1.1.1</span>.&#8194;</span><span data-line="14"></span>Immune dysregulation in COVID-19</h4>
<ul class="ul list-dash compact" data-line="15">
<li class="li ul-li list-dash-li compact-li" data-line="15"><span data-line="15"></span>is a consequence of elevation of cortisol, the stress hormone, and reduction of serotonin
</li>
<li class="li ul-li list-dash-li compact-li" data-line="16"><span data-line="16"></span>Stressful conditions associated with infection had shown to cause an elevation in the levels of the inflammatory mediator IL-6 that causes a decrease in the number and activity of cytotoxic T-cells and natural killer (NK) cells
</li>
<li class="li ul-li list-dash-li compact-li" data-line="17"><span data-line="17"></span>Elevated inflammatory cytokines have been shown to precipitate inflammations in many organs especially lung which is a serious condition and a main cause of mortality in COVID-19
</li></ul>
<h4 id="sec-5-ht-and-immnunity" class="h3" data-line="19" data-heading-depth="3" style="display:block"><span data-line="19"></span><span class="heading-before"><span class="heading-label">1.1.2</span>.&#8194;</span><span data-line="19"></span>5-HT and immnunity</h4>
<ul class="ul list-dash compact" data-line="20">
<li class="li ul-li list-dash-li compact-li" data-line="20"><span data-line="20"></span>5-HT has been found to regulate innate and adaptive immune responses
</li>
<li class="li ul-li list-dash-li compact-li" data-line="21"><span data-line="21"></span>Elevated cytokine levels have been shown to increase the rate of metabolism of serotonin due to activation of indoleamine-2,3-dioxygenase (IDO) enzyme that metabolizes tryptophan which is the precursor of serotonin
</li></ul>
<h4 id="sec-hypothesis" class="h3" data-line="23" data-heading-depth="3" style="display:block"><span data-line="23"></span><span class="heading-before"><span class="heading-label">1.1.3</span>.&#8194;</span><span data-line="23"></span>Hypothesis</h4>
<ul class="ul list-dash compact" data-line="24">
<li class="li ul-li list-dash-li compact-li" data-line="24"><span data-line="24"></span>Antidepressants are found to augment the immune system response through inhibiting pro-inflammatory factors, in particular CRP, TNF-α, IL-1β and IL-6
</li>
<li class="li ul-li list-dash-li compact-li" data-line="25"><span data-line="25"></span>SSRIs increase serotonin via proscribing its reuptake into the presynaptic cell then increasing the level of serotonin inside the synaptic cleft to bind the postsynaptic receptor
</li>
<li class="li ul-li list-dash-li compact-li" data-line="26"><span data-line="26"></span>This class had been proved to prevent the elevation of cytokine levels which causes depression
</li>
<li class="li ul-li list-dash-li compact-li" data-line="27"><span data-line="27"></span>In vitro antibacterial effect and modulation of antibiotic activity were also associated with using SSRIs
</li></ul>
<p align="center">
  <img width="460" height="300" style="padding:1px;border:thin solid black;" src="https://ars.els-cdn.com/content/image/1-s2.0-S096758682100120X-ga1_lrg.jpg"></br>
  Figure: Drug repurposing of SSRIs
</p>



<ul class="ul list-dash compact" data-line="34">
<li class="li ul-li list-dash-li compact-li" data-line="34"><span data-line="34"></span><strong class="strong-star2">In COVID-19 patients, SSRIs may help in hindering cytokine release syndrome that is responsible for aggravating sickness progression and the subsequent increase in TNFα</strong><span data-line="34"></span>
</li>
<li class="li ul-li list-dash-li compact-li" data-line="35"><span data-line="35"></span>SSRIs also have anti-coagulant properties
</li></ul>
<h4 id="sec-which-ssri-is-suited" class="h3" data-line="37" data-heading-depth="3" style="display:block"><span data-line="37"></span><span class="heading-before"><span class="heading-label">1.1.4</span>.&#8194;</span><span data-line="37"></span>Which SSRI is suited?</h4>
<ul class="ul list-dash compact" data-line="38">
<li class="li ul-li list-dash-li compact-li" data-line="38"><span data-line="38"></span><strong class="strong-star2">Sertraline</strong><span data-line="38"></span> wide therapeutic index
</li>
<li class="li ul-li list-dash-li compact-li" data-line="39"><span data-line="39"></span>low anticholinergic t/f good for elderly and cardiac
</li>
<li class="li ul-li list-dash-li compact-li" data-line="40"><span data-line="40"></span>shown to regulate pro-inflammatory cytokines
augment action of antibiotics against S. Aureus, E. Coli and P. Aeruginosa
</li>
<li class="li ul-li list-dash-li compact-li" data-line="42"><span data-line="42"></span>reduced influenza-induced lung inflammation when combined with oseltamivir in mouse model
</li></ul>

<p class="p noindent" data-line="44"><span data-line="44"></span>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382922/
</p>
<p class="p indent" data-line="46"><span data-line="46"></span>Additional reference
</p>
<ol class="ol loose" data-line="48">
<li class="li ol-li loose-li" data-line="48">
<p data-line="48"><span data-line="48"></span>Pashaei<span data-line="48"></span>&nbsp;<a href="https://www.sciencedirect.com/science/article/pii/S096758682100120X">J Clin Neuroscience 2021</a><span data-line="48"></span>
</p></li>
<li class="li ol-li loose-li" data-line="50">
<p data-line="50"><span data-line="50"></span>Navin<span data-line="50"></span>&nbsp;<a href="https://journals.sagepub.com/doi/full/10.1177/0253717620963338">Indian J Psychol Med</a><span data-line="50"></span>
</p></li></ol>
<h2 id="sec-fluvoxamine-vs-placebo-and-clinical-deterioration-in-outpatients-with-symptomatic-covid-19---a-randomized-clinical-trial" class="h1" data-line="52" data-heading-depth="1" style="display:block"><span data-line="52"></span><span class="heading-before"><span class="heading-label">2</span>.&#8194;</span><span data-line="52"></span>Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19<span data-line="52"></span> <span data-line="52"></span>- A Randomized Clinical Trial</h2><h3 id="sec-lenze-et-al-jama-2020" class="h2" data-line="54" data-heading-depth="2" style="display:block"><span data-line="54"></span><span class="heading-before"><span class="heading-label">2.1</span>.&#8194;</span><span data-line="54"></span>Lenze et al JAMA 2020</h3>
<ul class="ul list-dash loose" data-line="55">
<li class="li ul-li list-dash-li loose-li" data-line="55">
<p data-line="55"><span data-line="55"></span>Question: Does fluvoxamine, a selective serotonin reuptake inhibitor and σ-1 receptor agonist, prevent clinical deterioration in outpatients with acute coronavirus disease 2019 (COVID-19)?
</p></li>
<li class="li ul-li list-dash-li loose-li" data-line="56">
<p data-line="56"><span data-line="56"></span>Findings: In this randomized trial that included 152 adult outpatients with confirmed COVID-19 and symptom onset within 7 days, clinical deterioration occurred in 0 patients treated with fluvoxamine vs 6 (8.3%) patients treated with placebo over 15 days, a difference that was statistically significant.
</p></li>
<li class="li ul-li list-dash-li loose-li" data-line="57">
<p data-line="57"><span data-line="57"></span>Meaning: In this preliminary study, adult outpatients with symptomatic COVID-19 treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration over 15 days; however, determination of clinical efficacy would require larger randomized trials with more definitive outcome measures.
</p>
<p data-line="59"><span data-line="59"></span>https://jamanetwork.com/journals/jama/fullarticle/2773108
</p></li></ul>
<h2 id="sec-association-between-antidepressant-use-and-reduced-risk-of-intubation-or-death-in-hospitalized-patients-with-covid-19--results-from-an-observational-study" class="h1" data-line="61" data-heading-depth="1" style="display:block"><span data-line="61"></span><span class="heading-before"><span class="heading-label">3</span>.&#8194;</span><span data-line="61"></span>Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study</h2><h3 id="sec-hortel-el-al-molecular-psychiatry-2021" class="h2" data-line="63" data-heading-depth="2" style="display:block"><span data-line="63"></span><span class="heading-before"><span class="heading-label">3.1</span>.&#8194;</span><span data-line="63"></span>Hortel el al Molecular Psychiatry 2021</h3>
<ul class="ul list-dash compact" data-line="64">
<li class="li ul-li list-dash-li compact-li" data-line="64"><span data-line="64"></span>prior meta-analysis showed that antidepressant use in major depressive disorder was associated with reduced plasma levels of several pro-inflammatory mediators
</li>
<li class="li ul-li list-dash-li compact-li" data-line="65"><span data-line="65"></span>antidepressants may inhibit acid sphingomyelinase activity, which may prevent the infection of epithelial cells with SARS-CoV-2
</li>
<li class="li ul-li list-dash-li compact-li" data-line="66"><span data-line="66"></span>Observational multicenter retrospective cohort study<span data-line="66"></span> [PARIS]<span data-line="66"></span>
</li>
<li class="li ul-li list-dash-li compact-li" data-line="67"><span data-line="67"></span>Primary endpoint was a composite of intubation or death
</li>
<li class="li ul-li list-dash-li compact-li" data-line="68"><span data-line="68"></span>Of 7230 adults hospitalized for COVID-19, 345 patients (4.8%) received an antidepressant within 48 h of hospital admission.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="69"><span data-line="69"></span>Compared endpoint between patients who received antidepressants and those who did not in time-to-event analyses adjusted for patient characteristics, clinical and biological markers of disease severity, and other psychotropic medications
</li>
<li class="li ul-li list-dash-li compact-li" data-line="70"><span data-line="70"></span>Significant association between antidepressant use and reduced risk of intubation or death (HR, 0.56; 95% CI, 0.43–0.73, p <span data-line="70"></span>&lt;<span data-line="70"></span> 0.001).
</li>
<li class="li ul-li list-dash-li compact-li" data-line="71"><span data-line="71"></span>Association was also significant for SSRI and non-SSRI antidepressants, and for fluoxetine, paroxetine, escitalopram, venlafaxine, and mirtazapine (all p <span data-line="71"></span>&lt;<span data-line="71"></span> 0.05).
</li></ul>

<p class="p noindent" data-line="73"><span data-line="73"></span>https://www.nature.com/articles/s41380-021-01021-4
</p><h2 id="sec-bottom-line" class="h1" data-line="75" data-heading-depth="1" style="display:block"><span data-line="75"></span><span class="heading-before"><span class="heading-label">4</span>.&#8194;</span><span data-line="75"></span>Bottom line</h2>
<ul class="ul list-dash compact" data-line="76">
<li class="li ul-li list-dash-li compact-li" data-line="76"><span data-line="76"></span>Cytokines increase tryptophan metabolism (serotonin precursor) by increasing IDO enzyme activity
</li>
<li class="li ul-li list-dash-li compact-li" data-line="77"><span data-line="77"></span>Single RCT of Fluvoxamine an SSRI and σ-1 receptor agonist shown promise
</li>
<li class="li ul-li list-dash-li compact-li" data-line="78"><span data-line="78"></span>Observational study of those already on antidepressants, association with reduced intubation or death
</li>
<li class="li ul-li list-dash-li compact-li" data-line="79"><span data-line="79"></span>Possible MOA

<ul class="ul list-dash compact" data-line="80">
<li class="li ul-li list-dash-li compact-li" data-line="80"><span data-line="80"></span>Inhibition of acid sphingomyelinase activity<span data-line="80"></span> <span data-line="80"></span>-<span data-line="80"></span>&gt;<span data-line="80"></span> prevent further infection
</li>
<li class="li ul-li list-dash-li compact-li" data-line="81"><span data-line="81"></span>Reduced plasma proinflammatory cytokines
</li></ul></li>
<li class="li ul-li list-dash-li compact-li" data-line="82"><span data-line="82"></span>Sertraline has both σ-1 agonism and an SSRI, also cardiac safe and low risk of drug-srug ineractions<span data-line="82"></span> [OFF-LABEL USE??? ON CASE TO CASE BASIS; USE FOR RX OF COMORBID ANXIETY AND DEPRESSION WHRERE CLINCALLY INDICATED]<span data-line="82"></span>
</li>
<li class="li ul-li list-dash-li compact-li" data-line="83"><span data-line="83"></span>speculated ideal time to start once respiratory symptom begin to be worse (i.e. before the onset of acute lung injury)
</li>
<li class="li ul-li list-dash-li compact-li" data-line="84"><span data-line="84"></span>Navin et al have raised concerns about potential risks with SSRI in SARS-COV2, such as impaired coagulation, risk of arrhythmias, liver injury, and cytochrome-mediated drug interactions, which can potentially limit the use of SSRI in such patients
</li>
<li class="li ul-li list-dash-li compact-li" data-line="85"><span data-line="85"></span>Further double blind RCTs are required
</li></ul>
<span data-line=""></span></div>
</body>

</html>
